Asian Equities Outlook - Catching a falling knife

James Thom, Investment Director – Asian Equities, Aberdeen Standard Investments

Many people will view the prospect of investing in Asian equities right now as like catching a falling knife.

The perfect storm of a looming trade war, US dollar strength and rising interest rates have driven the MSCI Asia ex-Japan index down 16% this year to mid-November, by Bloomberg data, led by a 17.5% drop in China’s CSI300 Index.

Moreover, economic growth has started to slow across nations worldwide. This, together with the likelihood of more US rate hikes, threatens to peg Asian economies back further next year, especially those running deficits or dependent on oil imports.

Asian currencies are vulnerable to a strong dollar, with the Indian rupee, Indonesian Rupiah and Philippine peso most susceptible. Central banks in Jakarta and Manila have raised borrowing rates to defend their currencies – which promises to eat into companies’ profit margins.

US trade tariffs similarly threaten to undermine corporate earnings, particularly in China – which has become such a key driver of economic growth for countries across Asia Pacific.

With the impact of tariffs yet to be felt fully, fresh data point to a cooling of China’s economy, with fixed asset investment having sunk and indications that manufacturing activity is slowing.

All of this has sowed seeds of doubt in the minds of investors about the near-term prospects for Asian equities.

However, it’s not as though the People’s Bank of China has been sitting on its hands. The central bank has cut the reserve requirement ratio for liquid assets that banks need to hold as a buffer on their balance sheets by 2.5 percentage points this year.

It has also loosened policy to ensure sufficient credit is available in key areas of the economy, and has slashed tariffs on non-US imports to reduce costs for consumers and companies.

As an investor focused on value, when the herd moves in one direction, we tend to look the other way. We’re happy to go against the grain if the numbers tell us to.

The International Monetary Fund has forecast 6.6% growth for China this year, 7.3% for India and 5.3% for Asean. That’s comfortably more attractive than 3.7% for the world as a whole, 2.9% for the US and 2% for the Eurozone.

When we scrutinise businesses’ prospects, we still find good growth potential across Asia. Consensus company earnings forecasts are 11% for this year and 10% for next year1 . Pre-tax earnings and cash-flow yields have been rising and many firms are cash-rich.

Balance sheet strength gives companies options. They can invest in their own growth; they can maintain or raise dividend payouts; and they can pour money into research in areas such as tech innovation to help futureproof their firm. It’s all potentially good news for investors.

In addition, market corrections this year have driven regional valuations below historic averages. Mean price-to-earnings and price-to-book ratios for stocks on the MSCI Asia Pacific ex-Japan Index are below peers on MSCI World, MSCI US and MSCI Europe (table 1). The sell-off this year has made Asian equities look even more like a buy now.

These numbers reinforce our long-held conviction on the region. We’re confident that growing populations and rising middle classes and wealth can power domestic consumption for years. That encourages us to search for strong consumer companies well positioned to benefit from this structural dividend.

China has been orienting its economy successfully towards domestic consumption and services in a drive to become more self-sufficient. Revenues and costs for domestically focused firms are renminbi-based, with their customers and supply chains based in China. This will help to insulate them from RMB depreciation or the fallout of a trade war.

In a similar vein, average real wages in India are forecast to quadruple between 2013 and 2030 and its middle class to more than double to 547 million by 2025-26, based on figures from New Delhi-based think-tank the National Council of Applied Economic Research. Indian consumers will witness a major transformation in the next decade.

All of which, we believe, bodes well for company earnings next year and beyond.

Seizing on opportunities

We are a fundamental stock-picker, not a thematic investor. Our sector allocations are a reflection of where we have found firms we like. That said, we do take an industry’s outlook into consideration when we think about a company’s growth prospects.

In China we anticipate tailwinds for companies in insurance, travel, internet technology and those that deal in product essentials. These are things that people demand as they get richer, or feel they simply can’t do without.

We have capitalised on the recent correction to build up positions in companies and initiate new names. We are positive on firms in line to benefit from growth in tourism and trends such as electrification and autonomous driving.

In India, share price performance has been mixed across sectors this year. Financial services have been hit hard after infrastructure lender IL&FS suffered a debt default, with quality Indian banks caught up in the sell-off.

We think the price correction was unwarranted and predict a rebound in financially strong franchises with high deposit funding and a proven record of asset-liability management.

We are positive on the outlook for banks in general as we look ahead to next year. Monetary tightening by the US Federal Reserve has driven the dollar and prompted rate hikes around Asia. This should boost banks’ net interest margins, while stabilising credit costs will support earnings.

We are also optimistic about the outlook for IT companies, particularly leading semi-conductor players able to use their balance sheet strength to invest in cutting-edge next-generation technologies.

TABLE 1

Asia is attractively valued

Source: RIMES, MSCI, Morgan Stanley Research, 26 October 2018

1 Source: Factset, IBES, Goldman Sachs Global Investment Research, September 2018

 



Important Information

Aberdeen Standard Investments is a brand of the investment businesses of Aberdeen Asset Management and Standard Life Investments.

The MSCI information may only be used for your internal use, may not be reproduced or redisseminated in any form and may not be used as a basis for or a component of any financial instruments or products or indices. None of the MSCI information is intended to constitute investment advice or a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such. Historical data and analysis, should not be taken as an indication or guarantee of any future performance analysis forecast or prediction. The MSCI information is provided on an ‘as is’ basis and the user of this information assumes the entire risk of any use made of this information. MSCI, each of its affiliates and each other person involved in or related to compiling, computing or creating any MSCI information (collectively, the ‘MSCI’ Parties) expressly disclaims all warranties (including without limitation, any warranties of originality, accuracy, completeness, timeliness, non-infringement, merchantability and fitness for a particular purpose) with respect to this information. Without limiting any of the foregoing, in no event shall any MSCI Party have any liability for any direct, indirect, special, incidental, punitive, consequential (including, without limitation, lost profits) or any other damages (www.msci.com).

Bloomberg data are for illustrative purposes only. No assumptions regarding future performance should be made.

Important: This document is not an advertisement and does not constitute or form part of any offer or solicitation to issue, sell, subscribe or purchase any investment nor shall it or the fact of its distribution form the basis of or be relied on in connection with, any contract for the same. The contents in this document are for information, illustration or discussion purposes only and should not be construed as a recommendation to buy or sell any investment product and do not purport to represent or warrant the outcome of any investment product, strategy program or product. Reference to individual companies or any securities or funds is purely for the purpose of illustration only and is not and should not be construed as a recommendation to buy or sell, or advice in relation to investment, legal or tax matters. Any research or analysis used to derive, or in relation to, the above information has been procured by Aberdeen Standard Investments (Asia) Limited (‘Aberdeen Asia’) for its own use, without taking into account the investment objectives, financial situation or particular needs of any specific investor, and may have been acted on for Aberdeen Asia’s own purpose. Aberdeen Asia does not warrant the accuracy, adequacy or completeness of the information herein and expressly disclaims liability for any errors or omissions. The information is given on a general basis without obligation and on the understanding that any person acting upon or in reliance on it, does so entirely at his or her own risk. Past performance is not indicative of future performance. Any projections or other forward-looking statements regarding future events or performance of countries, markets or companies are not necessarily indicative of, and may differ from, actual events or results. Aberdeen Asia reserves the right to make changes and corrections to the information, including any opinions or forecasts expressed herein at any time, without notice. No reliance may be placed for any purpose on the information and opinions contained in this document or their accuracy or completeness. This document may not be reproduced in any form without the express permission of Aberdeen Asia and to the extent it is passed on, care must be taken to ensure that this reproduction is in a form that accurately reflects the information presented here.

RISK WARNING
The value of investments, and the income from them, can go down as well as up and you may get back less than the amount invested.

The views and conclusions expressed in this communication are for general interest only and should not be taken as investment advice or as an invitation to purchase or sell any specific security.

Any data contained herein which is attributed to a third party ("Third Party Data") is the property of (a) third party supplier(s) (the "Owner") and is licensed for use by Standard Life Aberdeen**. Third Party Data may not be copied or distributed. Third Party Data is provided "as is" and is not warranted to be accurate, complete or timely.

To the extent permitted by applicable law, none of the Owner, Standard Life Aberdeen** or any other third party (including any third party involved in providing and/or compiling Third Party Data) shall have any liability for Third Party Data or for any use made of Third Party Data. Past performance is no guarantee of future results. Neither the Owner nor any other third party sponsors, endorses or promotes the fund or product to which Third Party Data relates.

**Standard Life Aberdeen means the relevant member of Standard Life Aberdeen group, being Standard Life Aberdeen plc together with its subsidiaries, subsidiary undertakings and associated companies (whether direct or indirect) from time to time.